You just read:

Janssen Submits Supplemental New Drug Application to U.S. FDA for ZYTIGA® (abiraterone acetate) to Treat Men with Earlier Stages of Metastatic Prostate Cancer

News provided by

Janssen Biotech, Inc.

Sep 14, 2017, 16:03 ET